Handbook of Cannabis

Herausgeber: Pertwee, Roger

• Broschiertes Buch

Produktbeschreibung

Truly global in scope and with contributions from leading researchers around the world, The Handbook of Cannabis is the definitive resource on this fascinating drug. Combining scientific perspectives and clinical applications, it covers a vast array of topics, and will be valuable for anyone with an interest in this drug and its effects.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Hurst & Co.
• Seitenzahl: 784
• Erscheinungstermin: 1. Oktober 2016
• Englisch
• Abmessung: 246mm x 169mm x 48mm
• Gewicht: 1317g
• ISBN-13: 9780198792604
• ISBN-10: 0198792603
• Artikelnr.: 47864822

Autorenporträt

Roger Pertwee has three degrees from the University of Oxford: MA (in biochemistry), D.Phil. (in pharmacology) and D.Sc. (in physiological sciences). He is Professor of Neuropharmacology at the University of Aberdeen, Director of Pharmacology for GW Pharmaceuticals, co-chairman of the International Union of Basic and Clinical Pharmacology (IUPHAR) Subcommittee on Cannabinoid Receptors, a co-ordinator of the British Pharmacological Society's Special Interest Group on Cannabinoids, and visiting Professor at the University of Hertfordshire. He has also served as chairman of the International Association for Cannabinoid Medicines (IACM; 2005-2007) and twice as President of the International Cannabinoid Research Society (ICRS; 1997-1998; 2007-2008), and is currently ICRS International Secretary and also a member of the IACM board of directors.

Inhaltsangabe

* Part 1 Constituents, History, International Control, Cultivation and
Phenotypes of Cannabis
* 1: Mahmoud A. ElSohly and Waseem Gul: Constituents of Cannabis Sativa
* 2: Ethan B. Russo: The Pharmacological History of Cannabis
* 3: Alice P. Mead: International Control of Cannabis
* 4: David J. Potter: Cannabis Horticulture
* 5: Etienne de Meijer: Cannabis Phenotypes (Chemotypes) of Cannabis
* Part 2 Pharmacology, Pharmacokinetics, Metabolism and Forensics
* 6: Roger G. Pertwee and Maria Grazia Cascio: Known Pharmacological
Actions of Delta-9-Tetrahydrocannabinol and of Four Other Chemical
Constituents of Cannabis that Activate Cannabinoid Receptors
* 7: Maria Grazia Cascio and Roger G. Pertwee: Known Pharmacological
Actions of Nine Non-Psychotropic Phytocannabinoids
* 8: Bela Szabo: Effects of Phytocannabinoids on Neurotransmission in
the Central and Peripheral Nervous Systems
* 9: Eliot L. Gardner: Cannabinoids and Addiction
* 10: Sachin Patel, Matthew N. Hill, and Cecilia J. Hillard.: Effects
of Phytocannabinoids on Anxiety, Mood, and the Endocrine System
* 11: Saoirse E. O'Sullivan: Phytocannabinoids and the Cardiovascular
System
* 12: Marnie Duncan and Angelo A. Izzo: Phytocannabinoids and the
Gastrointestinal System
* 13: Jordyn M. Stuart, Emma Leishman, and Heather B. Bradshaw:
Reproduction and Cannabinoids: Ups and Downs, Ins and Outs
* 14: Guy A. Cabral, Erinn S. Raborn, and Gabriela A. Ferreira:
Phytocannabinoids and the Immune System
* 15: John M. McPartland and Ethan B. Russo: Non-Phytocannabinoid
Constituents of Cannabis and Herbal Synergy
* 16: Marilyn A. Huestis and Michael L. Smith: Cannabinoid
Pharmacokinetics and Disposition in Alternative Matrices
* Part 3 Medicinal Cannabis and Cannabinoids: Clinical Data
* 17: Arno Hazekamp and George Pappas: Self-Medication with Cannabis
* 18: Amanda Reiman: Cannabis Distribution: Coffee Shops to
Dispensaries
* 19: Alison Thompson and Verity Langfield: Development of
Cannabis-Based Medicines: Regulatory Hurdles/Routes in Europe and the
United States
* 20: Stephen Wright and Geoffrey Guy: Licensed Cannabis-Based
Medicines: Benefits and Risks
* 21: Mark A. Ware: Synthetic Psychoactive Cannabinoids Licensed as
Medicines
* 22: William Notcutt and Emily L. Clarke: Cannabinoids in Clinical
Practice: A UK Perspective
* Part 4 Approved Therapeutic Targets for Phytocannabinoids:
Preclinical Pharmacology
* 23: Erin M. Rock, Martin A. Sticht, and Linda A. Parker: Effect of
Phytocannabinoids on Nausea and Vomiting
* 24: Luigia Cristino and Vincenzo Di Marzo: Established and Emerging
Concepts of Cannabinoid Action on Food Intake and their Potential
Application to the Treatment of Anorexia and Cachexia
* 25: Barbara Costa and Francesca Comelli: Pain
* 26: Gareth Pryce and David Baker: Cannabis and Multiple Sclerosis
* Part 5 Some Potential Theraputic Targets for Phytocannabinoids
* 27: Javier Fernández-Ruiz, Eva de Lago, María Gómez-Ruiz, Concepción
García, Onintza Sagredo, and Moisés García-Arencibia:
Neurodegenerative Disorders Other Than Multiple Sclerosis
* 28: Daniela Parolaro, Erica Zamberletti and Tiziana Rubino:
Cannabidiol/Phytocaanabinoids: A New Opportunity for Schizophrenia
Treatment
* 29: Eric Murillo-Rodríguez, Lisa Aguilar-Turton, Stephanie
Mijangos-Moreno, Andrea Sarro-Ramírez, and Óscar Arias-Carrión:
Phytocannabinoids as Novel Therapeutic Agents for Sleep Disorders
* 30: Claire M. Williams, Nicholas A. Jones and Benjamin J. Whalley:
Cannabis and Epilepsy
* 31: Pál Pacher and George Kunos: Cardiovascular, Metabolic, Liver,
Kidney, and Inflammatory Disorders
* 32: Sergio Oddi and Mauro Maccarrone: Phytocannabinoids and Skin
Disorders
* 33: Heping Xu and Augusto Azuara-Blanco: Phytocannabinoids in
Degenerative and Inflammatory Retinal Diseases: Glaucoma, Age-Related
Macular Degeneration, Diabetic Retinopathy and Uveoretinitis
* 34: Itai Bab: Bone As a Target for Cannabinoid Therapy
* 35: Guillermo Velasco, Cristina Sánchez, and Manuel Guzmán: Cancer
* Part 6 Recreational Cannabis: Sought-After Effects, Adverse Effects,
Designer Drugs and Harm Minimization
* 36: H. Valerie Curran and Celia J. A. Morgan: Desired and Undesired
Effects of Cannabis on the Human Mind and Psychological Well-Being
* 37: Paul D. Morrison, Sagnik Bhattacharyya, and Robin M. Murray:
Recreational Cannabis: The Risk of Schizophrenia
* 38: Franjo Grotenhermen: Nonpsychological Adverse Effects
* 39: Wayne Hall and Louisa Degenhardt: Harm Reduction Policies for
Cannabis
* 40: Brian F. Thomas, Jenny L. Wiley, Gerald T. Pollard, and Megan
Grabenauer: Cannabinoid Designer Drugs: Effects and Forensics